Bar code documentation of pharmacotherapy services in intensive care units

Pharmacotherapy

Volumn 16, Issue 2 I, 1996, Pages 261-266

  Zarowitz, Barbara J ^a   Petitta, Antonio ^a   Rudis, Maria I ^a   Horst, H Mathilda ^a   Hyzy, Robert ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; DRUG; NEUROMUSCULAR BLOCKING AGENT; SEDATIVE AGENT; THEOPHYLLINE DERIVATIVE; VANCOMYCIN;

ARTICLE; CRITICAL ILLNESS; DRUG MONITORING; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MEDICAL DOCUMENTATION; PATIENT CARE; PHARMACIST; TECHNOLOGY;

AUTOMATIC DATA PROCESSING; DRUG THERAPY, COMPUTER-ASSISTED; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; PHARMACY SERVICE, HOSPITAL;

EID: 0030005033     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults Chest 1991,100:1619-36.
2. Wagner DP, Knaus WA, Harrell FE, Zimmerman JE, Watts C. Daily prognostic estimates for critically ill adults in intensive care units: results from a prospective, multicenter, inception cohort analysis Crit Care Med 1994;22:1359-72.
3. Dasta JF, Jacobi J, Armstrong DK. Role of the pharmacist in caring for the critically ill patient. In: Chernow B, ed. The pharmacologic approach to the critically ill patient, 3rd ed. Baltimore: Williams & Wilkins, 1994:156-66.
4. Miller DA, Zarowitz BJ, Petitta A, Wright DB. Pharmacy technicians and computer technology to support clinical pharmacy services. Am J Hosp Pharm 1993;50.929-34
5. Zarowitz BJ, Petitta A, Mlynarek M, et al. Bar code technology applied to drug-use evaluation Am J Hosp Pharm 1993,50:935-9.
6. Miller DA, Stankiewicz RF, Zarowitz BJ, Baumann TJ, Wright DJ. Developing and implementing standards of practice for clinical pharmacy services. Hosp Pharm 1987;22:772-83.
7. Montazeri M, Cook DJ. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 1994;22:1044-8
8. Hassan Y, Aziz NA, Awang J, Aminuldin AG. An analysis of clinical pharmacist interventions in an intensive care unit. J Clin Pharm Ther 1992;17:347-51
9. Tom E, Chin T. Provision of pharmaceutical care to intensive care unit patients [abstr]. Pharmacotherapy 1994;14:352-3.
10. Chuang LC, Sutton JD, Henderson GT. Impact of a clinical pharmacist on cost saving and cose avoidance in drug therapy in an intensive care unit. Hosp Pharm 1994;29:215-18.
11. Smythe MA, Melendy S, Jahns B, Dmuchowski C. An exploratory analysis of medication utilization in a medical intensive care unit. Crit Care Med 1993;21:1319-23.
12. Boucher BA, Kuhl DA, Coffey BC, Fabian TC. Drug use in a trauma intensive care unit. Am J Hosp Pharm 1990,47 805-10.
13. Dasta JF, Segal R, Cunningham A. National survey of critical care pharmaceutical services. Am J Hosp Pharm 1989,46: 2308-12.
14. Cooper SL, Zaske DE. Relationship between intensity of hospital services and pharmacy workload. Am J Hosp Pharm 1987,44.2267-71.
15. Iglar AM, Osland CS, Ploetz PA, Thielke TS. Time and cost requirements for decentralized pharmacist activities Am J Hosp Pharm 1990;47:572-8.
16. Dasta JF, Armstrong DKI. Pharmacoeconomic impact of critically ill surgical patients. Drug Intell Clin Pharm 1988,22:994-8
17. Vassar MJ, Holcroft JW. The case against using the APACHE system to predict intensive care unit outcome in trauma patients. Crit Care Clin 1994; 10 117-26, 127-34.